{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-184625","form_type":"8-K","ticker":"SRPT","cik":"0000873303","company_name":"Sarepta Therapeutics, Inc.","filed_at":"2025-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.532779+00:00","generated_at":"2026-05-17T11:00:33.864338+00:00","sec_items":["3.02"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sarepta exchanges $700M of 1.25% notes due 2027 for new 4.875% notes due 2030, stock, and cash","bullets":["Exchanged ~$700M existing 1.25% convertible notes for $602M new 4.875% notes due 2030, $110M stock, and ~$123.3M cash.","New notes conversion price ~$60/share, representing a 191.5% premium over the $20.58 Aug 20 closing price.","Private placement of $20M common stock to J. Wood Capital Advisors at price with floor of $14.41/share.","Up to 835,765 fee shares may be issued to J. Wood Capital Advisors for advisory services.","Exchange expected to close Aug 28, 2025, subject to customary closing conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-184625","json":"https://secwatch.observer/filing/0001193125-25-184625.json","markdown":"https://secwatch.observer/filing/0001193125-25-184625.md","text":"https://secwatch.observer/filing/0001193125-25-184625.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/873303/000119312525184625/0001193125-25-184625-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/873303/000119312525184625/d938350d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:00:33.864338+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}